Relative risks of all-cause and CVD mortality associated with the NCEP, NCEP-R, and IDF definitions of the metabolic syndrome in 20,789 men 20–83 years of age from the ACLS
. | n . | No. deaths (CVD) . | Man-years of follow-up . | All-cause mortality . | . | CVD mortality . | . | ||
---|---|---|---|---|---|---|---|---|---|
. | . | . | . | RR (95% CI)* . | RR (95% CI)† . | RR (95% CI)* . | RR (95% CI)† . | ||
NCEP | |||||||||
No | 16,692 | 449 (134) | 193,748 | 1.00 (ref.) | 1.00 (ref.) | 1.00 (ref.) | 1.00 (ref.) | ||
Yes | 4,097 | 183 (79) | 43,063 | 1.46 (1.23–1.74) | 1.36 (1.14–1.62) | 2.03 (1.54–2.69) | 1.79 (1.35–2.37) | ||
NCEP-R | |||||||||
No | 15,194 | 399 (118) | 177,515 | 1.00 (ref.) | 1.00 (ref.) | 1.00 (ref.) | 1.00 (ref.) | ||
Yes | 5,595 | 233 (95) | 59,296 | 1.41 (1.21–1.67) | 1.31 (1.11–1.54) | 1.89 (1.44–2.47) | 1.67 (1.27–2.19) | ||
IDF | |||||||||
No | 14,546 | 385 (112) | 170,780 | 1.00 (ref.) | 1.00 (ref.) | 1.00 (ref.) | 1.00 (ref.) | ||
Yes | 6,243 | 247 (101) | 66,030 | 1.36 (1.16–1.60) | 1.26 (1.07–1.49) | 1.86 (1.42–2.44) | 1.67 (1.27–2.20) |
. | n . | No. deaths (CVD) . | Man-years of follow-up . | All-cause mortality . | . | CVD mortality . | . | ||
---|---|---|---|---|---|---|---|---|---|
. | . | . | . | RR (95% CI)* . | RR (95% CI)† . | RR (95% CI)* . | RR (95% CI)† . | ||
NCEP | |||||||||
No | 16,692 | 449 (134) | 193,748 | 1.00 (ref.) | 1.00 (ref.) | 1.00 (ref.) | 1.00 (ref.) | ||
Yes | 4,097 | 183 (79) | 43,063 | 1.46 (1.23–1.74) | 1.36 (1.14–1.62) | 2.03 (1.54–2.69) | 1.79 (1.35–2.37) | ||
NCEP-R | |||||||||
No | 15,194 | 399 (118) | 177,515 | 1.00 (ref.) | 1.00 (ref.) | 1.00 (ref.) | 1.00 (ref.) | ||
Yes | 5,595 | 233 (95) | 59,296 | 1.41 (1.21–1.67) | 1.31 (1.11–1.54) | 1.89 (1.44–2.47) | 1.67 (1.27–2.19) | ||
IDF | |||||||||
No | 14,546 | 385 (112) | 170,780 | 1.00 (ref.) | 1.00 (ref.) | 1.00 (ref.) | 1.00 (ref.) | ||
Yes | 6,243 | 247 (101) | 66,030 | 1.36 (1.16–1.60) | 1.26 (1.07–1.49) | 1.86 (1.42–2.44) | 1.67 (1.27–2.20) |
Adjusted for age and year of examination.
Adjusted for age, year of examination, smoking, alcohol consumption, parental history of premature CVD, and possible CVD at baseline.